HARRISBURG, Pa. (WHTM) — On Friday evening, the Pennsylvania Department of Health announced the Johnson & Johnson vaccine pause has been lifted, allowing all COVID-19 vaccine providers in the Commonwealth to begin administering the vaccine again.
The Food and Drug Administration, along with the CDC, reviewed the six reported incidents of blood clot development in women who received the single-dose vaccine within two weeks of becoming immunized.
Want the latest on the coronavirus vaccine in Pa.? Visit acb27.com/vaccine for more information.
As a result, the CDC recommended putting the Janssen Johnson & Johnson vaccine on hold for about 10 days. On Friday afternoon, the CDC Advisory Committee on Immunization Practices held an emergency meeting and updated their guidance on vaccine distribution.
The agency reported the J&J vaccine is not only safe, but also effective for individuals, and the six blood clot cases were “extremely rare.”
“After a thorough review, federal experts have determined that the Johnson & Johnson vaccine is safe for all individuals,” Acting Secretary of Health Alison Beam said. “We continue to urge individuals to get vaccinated as soon as possible with any of the three vaccines available to them. Getting vaccinated is essential as we work to prevent the spread of COVID-19, and also of serious and fatal complications due to the virus.”